BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hammami MB, Garibaldi B, Shah P, Liu G, Jain T, Chen PH, Kim AK, Avdic E, Petty B, Strout S, Fine DM, Niranjan-Azadi A, Garneau WM, Cameron AM, Monroy Trujillo JM, Gurakar A, Avery R. Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: A case report. Am J Transplant 2020;20:2254-9. [PMID: 32359210 DOI: 10.1111/ajt.15985] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Alasfar S, Avery RK. The impact of COVID-19 on kidney transplantation. Nat Rev Nephrol 2020;16:568-9. [PMID: 32788747 DOI: 10.1038/s41581-020-00340-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
2 Metawea MI, Yousif WI, Moheb I. COVID 19 and liver: An A-Z literature review. Dig Liver Dis. 2021;53:146-152. [PMID: 32988758 DOI: 10.1016/j.dld.2020.09.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
3 [DOI: 10.1101/2020.10.22.20216317] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Mirzaie H, Vahidi M, Shokoohi M, Darvishian M, Sharifi H, Sharafi H, Karamouzian M. COVID-19 Among Patients With Hepatitis B or Hepatitis C: A Systematic Review. Hepat Mon 2021;20. [DOI: 10.5812/hepatmon.111617] [Reference Citation Analysis]
5 Mansourabadi AH, Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N. The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19. Life Sci 2020;258:118185. [PMID: 32750438 DOI: 10.1016/j.lfs.2020.118185] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 23.5] [Reference Citation Analysis]
6 Ammirati E, Travi G, Orcese C, Sacco A, Auricchio S, Frigerio M, Puoti M. Heart-Kidney Transplanted patient affected by COVID-19 pneumonia treated with tocilizumab on top of immunosuppressive maintenance therapy. Int J Cardiol Heart Vasc 2020;29:100596. [PMID: 32754630 DOI: 10.1016/j.ijcha.2020.100596] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Fernández-Ruiz M, Aguado JM. Immunomodulatory Therapies for COVID-19 in Solid Organ Transplant Recipients. Curr Transplant Rep 2020;:1-11. [PMID: 33110739 DOI: 10.1007/s40472-020-00306-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Aziz H, Lashkari N, Yoon YC, Kim J, Sher LS, Genyk Y, Kwon YK. Effects of Coronavirus Disease 2019 on Solid Organ Transplantation. Transplant Proc 2020;52:2642-53. [PMID: 33127076 DOI: 10.1016/j.transproceed.2020.09.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
9 Moosavi SA, Mashhadiagha A, Motazedian N, Hashemazar A, Hoveidaei AH, Bolignano D. COVID-19 clinical manifestations and treatment strategies among solid-organ recipients: A systematic review of cases. Transpl Infect Dis 2020;22:e13427. [PMID: 32779820 DOI: 10.1111/tid.13427] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
10 Corse T, Dayan L, Kersten S, Battaglia F, Terlecky SR, Han Z. Clinical Outcomes of COVID-19 Patients with Pre-existing, Compromised Immune Systems: A Review of Case Reports. Int J Med Sci 2020;17:2974-86. [PMID: 33173418 DOI: 10.7150/ijms.50537] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
11 Barbara I, Silvia M, Dario T, Giuseppe C, Stallone G. Case Report: Tocilizumab for Acute Kidney Graft Dysfunction in Patient Affected by COVID-19. Front Med (Lausanne) 2021;8:732792. [PMID: 34901054 DOI: 10.3389/fmed.2021.732792] [Reference Citation Analysis]
12 Samidoust P, Nikoupour H, Hemmati H, Samidoust A. Clinical Manifestations and Characterization of COVID-19 in Liver Transplant Recipients: A Systematic Review of Case Reports and Case Series. Ethiop J Health Sci 2021;31:429-38. [PMID: 34158795 DOI: 10.4314/ejhs.v31i2.26] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Quante M, Brake L, Tolios A, Della Penna A, Steidle C, Gruendl M, Grishina A, Haeberle H, Guthoff M, Tullius SG, Königsrainer A, Nadalin S, Löffler MW. SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020. Transplant Proc 2021;53:2421-34. [PMID: 34551880 DOI: 10.1016/j.transproceed.2021.08.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Parente A, Manzia TM, Angelico R, Tirotta F, Muiesan P, Tisone G, Framarino Dei Malatesta M. COVID-19, liver transplant, and immunosuppression: Allies or foes? Transpl Infect Dis 2021;23:e13417. [PMID: 32666588 DOI: 10.1111/tid.13417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Jamir I, Lohia P, Pande RK, Setia R, Singhal AK, Chaudhary A. Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia. Ann Hepatobiliary Pancreat Surg 2020;24:526-32. [PMID: 33234758 DOI: 10.14701/ahbps.2020.24.4.526] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
16 Karruli A, Spiezia S, Boccia F, Gagliardi M, Patauner F, Salemme A, Maiello C, Zampino R, Durante-Mangoni E. Effect of immunosuppression maintenance in solid organ transplant recipients with COVID-19: Systematic review and meta-analysis. Transpl Infect Dis 2021;:e13595. [PMID: 33641202 DOI: 10.1111/tid.13595] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Pereira MR, Aversa MM, Farr MA, Miko BA, Aaron JG, Mohan S, Cohen DJ, Husain SA, Ratner LE, Arcasoy S, Uriel N, Zheng EX, Fox AN, Tsapepas DS, Emond JC, Verna EC. Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study. Am J Transplant 2020;20:3198-205. [PMID: 32946668 DOI: 10.1111/ajt.16314] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
18 Strauss AT, Boyarsky BJ, Garonzik-Wang JM, Werbel W, Durand CM, Avery RK, Jackson KR, Kernodle AB, Baker T, Snyder J, Segev DL, Massie AB. Liver transplantation in the United States during the COVID-19 pandemic: National and center-level responses. Am J Transplant 2021;21:1838-47. [PMID: 33107180 DOI: 10.1111/ajt.16373] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
19 Mirjalili M, Shafiekhani M, Vazin A. Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen. Ther Clin Risk Manag 2020;16:617-29. [PMID: 32694915 DOI: 10.2147/TCRM.S256246] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
20 Dastan F, Nadji SA, Saffaei A, Tabarsi P. Tocilizumab administration in a refractory case of COVID-19. Int J Antimicrob Agents 2020;56:106043. [PMID: 32502524 DOI: 10.1016/j.ijantimicag.2020.106043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
21 Ferrari F, Visconti F, De Amici M, Guglielmi A, Colombo CN, Belliato M, Ronco C. Coronavirus disease 2019 in critically ill patients: can we re-program the immune system? A primer for Intensivists. Minerva Anestesiol 2020;86:1214-33. [PMID: 32755094 DOI: 10.23736/S0375-9393.20.14663-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Renaud-Picard B, Gallais F, Ohana M, Zeyons F, Kretz B, Andre J, Sattler L, Hirschi S, Kessler R. Bilateral Acute Cardioembolic Limb Ischemia After Coronavirus Disease 2019 Pneumonia in a Lung Transplant Recipient: A Case Report. Transplant Proc 2020;52:2715-8. [PMID: 32713821 DOI: 10.1016/j.transproceed.2020.06.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
23 Imam A, Abukhalaf SA, Merhav H, Abu-Gazala S, Cohen-Arazi O, Pikarsky AJ, Safadi R, Khalaileh A. Prognosis and Treatment of Liver Transplant Recipients in the COVID-19 Era: A Literature Review. Ann Transplant. 2020;25:e926196. [PMID: 33106469 DOI: 10.12659/aot.926196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
24 Pérez-Sáez MJ, Blasco M, Redondo-Pachón D, Ventura-Aguiar P, Bada-Bosch T, Pérez-Flores I, Melilli E, Sánchez-Cámara LA, López-Oliva MO, Canal C, Shabaka A, Garra-Moncau N, Martín-Moreno PL, López V, Hernández-Gallego R, Siverio O, Galeano C, Espí-Reig J, Cabezas CJ, Rodrigo MT, Llinàs-Mallol L, Fernández-Reyes MJ, Cruzado-Vega L, Pérez-Tamajón L, Santana-Estupiñán R, Ruiz-Fuentes MC, Tabernero G, Zárraga S, Ruiz JC, Gutiérrez-Dalmau A, Mazuecos A, Sánchez-Álvarez E, Crespo M, Pascual J; Spanish Society of Nephrology COVID-19 Group. Use of tocilizumab in kidney transplant recipients with COVID-19. Am J Transplant 2020;20:3182-90. [PMID: 32654422 DOI: 10.1111/ajt.16192] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 14.5] [Reference Citation Analysis]
25 Waisberg DR, Abdala E, Nacif LS, Haddad LB, Ducatti L, Santos VR, Gouveia LN, Lazari CS, Martino RB, Pinheiro RS, Arantes RM, Terrabuio DR, Malbouisson LM, Galvao FH, Andraus W, Carneiro-D'Albuquerque LA. Liver transplant recipients infected with SARS-CoV-2 in the early postoperative period: Lessons from a single center in the epicenter of the pandemic. Transpl Infect Dis 2021;23:e13418. [PMID: 32667716 DOI: 10.1111/tid.13418] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
26 Loinaz C, Marcacuzco A, Fernández-Ruiz M, Caso O, Cambra F, San Juan R, Justo I, Calvo J, García-Sesma A, Manrique A, Pérez-Jacoiste Asín MA, Folgueira MD, Aguado JM, Lumbreras C. Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: Initial experience at a single center in Madrid, Spain. Transpl Infect Dis 2020;22:e13372. [PMID: 32562561 DOI: 10.1111/tid.13372] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
27 Coll E, Fernández-Ruiz M, Sánchez-Álvarez JE, Martínez-Fernández JR, Crespo M, Gayoso J, Bada-Bosch T, Oppenheimer F, Moreso F, López-Oliva MO, Melilli E, Rodríguez-Ferrero ML, Bravo C, Burgos E, Facundo C, Lorenzo I, Yañez Í, Galeano C, Roca A, Cabello M, Gómez-Bueno M, García-Cosío M, Graus J, Lladó L, de Pablo A, Loinaz C, Aguado B, Hernández D, Domínguez-Gil B; Spanish Group for the Study of COVID-19 in Transplant Recipients. COVID-19 in transplant recipients: The Spanish experience. Am J Transplant 2021;21:1825-37. [PMID: 33098200 DOI: 10.1111/ajt.16369] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 17.5] [Reference Citation Analysis]